Human Papillomavirus Vaccination for Adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human Papillomavirus Vaccination for Adults

Published:2020-02-04 Issue:5 Volume:323 Page:468
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Oshman Lauren D.¹²,Davis Andrew M.³

Affiliation:

1. Department of Family Medicine, University of Chicago, Chicago, Illinois

2. Northshore University Health System, Glenview, Illinois

3. Department of Medicine, Section of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2758932/jama_oshman_2020_gs_190013.pdf

Reference9 articles.

1. Prevalence of HPV infection among females in the United States.;Dunne;JAMA,2007

2. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.;Meites;MMWR Morb Mortal Wkly Rep,2019

3. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.;Castellsagué;Br J Cancer,2011

4. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland.;Palmer;BMJ,2019

5. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes.;Drolet;Lancet,2019

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, and attitude of medical students about role of human papilloma virus, and vaccine in head and neck cancer;Oral Oncology;2024-09

2. Factors Associated with HPV Vaccination Among Middle‐Aged Adults in the United States;Otolaryngology–Head and Neck Surgery;2024-08-27

3. Analysis of the global burden of cervical cancer in young women aged 15–44 years old;European Journal of Public Health;2024-05-16

4. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45;The Laryngoscope;2024-02-24

5. Efficacy and immunogenicity of AS04‐HPV‐16/18 vaccine in females with existing cervical HR‐HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide;International Journal of Cancer;2024-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3